These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26327627)

  • 1. Mechanism of generation of drug nanocrystals in celecoxib: mannitol nanocrystalline solid dispersion.
    Bhatt V; Shete G; Bansal AK
    Int J Pharm; 2015 Nov; 495(1):132-139. PubMed ID: 26327627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology.
    Shete G; Pawar YB; Thanki K; Jain S; Bansal AK
    Mol Pharm; 2015 Apr; 12(4):1158-70. PubMed ID: 25785392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual drug nanocrystals loaded microparticles for fixed dose combination of simvastatin and ezetimibe.
    Nandi S; Kaur A; Bansal AK
    Pharm Dev Technol; 2020 Jan; 25(1):40-53. PubMed ID: 31524550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Mannitol on Nucleation and Crystal Growth of Amorphous Flavonoids: Implications on the Formation of Nanocrystalline Solid Dispersion.
    Shete G; Modi SR; Bansal AK
    J Pharm Sci; 2015 Nov; 104(11):3789-3797. PubMed ID: 26183113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of surfactants on the crystal growth of amorphous celecoxib.
    Mosquera-Giraldo LI; Trasi NS; Taylor LS
    Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles.
    Chen J; Ormes JD; Higgins JD; Taylor LS
    Mol Pharm; 2015 Feb; 12(2):533-41. PubMed ID: 25569461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freeze-dried amorphous dispersions for solubility enhancement of thermosensitive API having low molecular lipophilicity.
    Kulthe VV; Chaudhari PD; Aboul-Enein HY
    Drug Res (Stuttg); 2014 Sep; 64(9):493-8. PubMed ID: 24443307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Frequency Raman Spectroscopic Study on Compression-Induced Destabilization in Melt-Quenched Amorphous Celecoxib.
    Be Rziņš KR; Fraser-Miller SJ; Rades T; Gordon KC
    Mol Pharm; 2019 Aug; 16(8):3678-3686. PubMed ID: 31246479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NanoCrySP technology for generation of drug nanocrystals: translational aspects and business potential.
    Shete G; Bansal AK
    Drug Deliv Transl Res; 2016 Aug; 6(4):392-8. PubMed ID: 26912190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Surface Characteristics of Mannitol in Crystallization of Fenofibrate During Spray Drying.
    Thakur PS; Thakore SD; Bansal AK
    J Pharm Sci; 2020 Feb; 109(2):1105-1114. PubMed ID: 31705872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Effect of the Preparation Method and Compression on the Physical Stability and Dissolution Behavior of Melt-Quenched Amorphous Celecoxib.
    Be Rziņš KR; Fraser-Miller SJ; Di R; Liu J; Peltonen L; Strachan CJ; Rades T; Gordon KC
    Mol Pharm; 2021 Mar; 18(3):1408-1418. PubMed ID: 33586988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions.
    Song S; Wang C; Zhang B; Sun CC; Lodge TP; Siegel RA
    J Pharm Sci; 2023 Jan; 112(1):204-212. PubMed ID: 36030843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microscopic Cracks Modulate Nucleation and Solid-State Crystallization Tendency of Amorphous Celecoxib.
    Thakore SD; Das K; Dalvi SV; Reddy CM; Bansal AK
    Mol Pharm; 2024 Jan; 21(1):76-86. PubMed ID: 38051598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.